RT

Rob Tucci

Director at Drusolv Therapeutics

Houston, Texas

Overview

Work Experience

  • Director

    2022 - Current

  • Managing Director

    2012

  • Member Investor

    2012

    One of four Board Members of this early stage fund series. Responsibilities include investments sourcing, investments negotiation, business management, fund raising and administration. The Texas Halo Fund is capitalized at approximately $25M and invests in promising early stage companies. Areas of responsibility include science and life science sectors.

  • Director

    2013

    Adient Medical is a seed stage medical device company with revolutionary absorbable technology.

  • General Manager

    2005

    Develop performance chemicals, source and supply to South American mining companies for mineral separation. Angel Investments - science and life science

  • President

    1995 - 2016

    Chemicals, Investments, Real Estate

  • Chair, Life Science 2012-2018

    2006 - 2018

    12 year member of the Houston Angel Network

  • Advisor

    2014 - 2018

  • Judge, Cougar Fund; Technology Gap Fund; Guest Lecturer

    2012 - 2016

  • Judge; Guest Lecturer

    2012 - 2016

  • Board of Directors

    2011 - 2013

    Volunteer, non-profit

  • Director, Feedstocks and Energy

    1993 - 1995

Relevant Websites